Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET-MRI exploration of cluster headache pathophysiology using [18F]F13640
2021-000209-25Phase 2Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of NLX-112 in Cluster Headache (CH) and migraine (3 arms), sponsored by Hospices Civils de Lyon. Started Jul 2021; status: active.
02
Drugs
NLX-112
03
Conditions
Cluster Headache (CH)migraine
Beyond the preview
Go deeper on 2021-000209-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000209-25.